Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor.

Top Gene Interactions

Related Pathways

General Information

Mechanism of Action

Fulvestrant Interacts with Diseases

Fulvestrant Interacts with Genes